A bioorthogonal antibody-based chemically-induced-dimerization switch for therapeutic application
Martinko, A. J.; Tran, H. L.; Simonds, E. F.; Cooke, A. L.; Huang, Z.; Raguveer, S.; Agullet, J. P.; Prasad, S.; Going, C.; Marshall, L.; Park, T.; Banerjee, S.; Macdonald, R.; Jian, M.; Ng, K.; Palakodaty, A.; Kaur, M.; Ponce, A.; Tabrizi, M.; Hill, Z. B.
Show abstract
We present the Indinavir Ligand Induced Transient Engagement switch (IDV LITE Switch), a fully synthetic Chemically Induced Dimerization (CID) system wherein two humanized antibody fragments are heterodimerized by the antiviral drug indinavir. The IDV LITE Switch represents the first CID system made from fully humanized protein components and dimerized by a clinically approved small molecule drug lacking a mammalian target, making it an ideal bioorthogonal molecular switch for application in small-molecule controlled therapeutics.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Identification of Covalent Cyclic Peptide Inhibitors Targeting Protein-Protein Interactions Using Phage Display 95%
- Macrocyclic phage display for identification of selective protease substrates 94%
- Using a function-first "scout fragment"-based approach to develop allosteric covalent inhibitors of conformationally dynamic helicase mechanoenzymes 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.